Since 2005, Daewoong has grown alongside Indonesia—developing talent, advancing science, and strengthening the nation’s healthcare ecosystem. Today, we are proudly building Indonesia’s future as a powerhouse in biopharmaceuticals, stem cells, botulinum toxin, chemicals, and medical devices through active local production and shared-growth initiatives.

Our transformation goes far beyond pharmaceuticals. We are shaping Indonesia’s next era of innovation across biotechnology, medical devices, and wellness—building a vibrant industry “by Indonesians, for Indonesians.”

Together with leading universities such as UI, ITB, and IPB, we have established four research institutes that accelerate scientific discovery and nurture the next generation of researchers. We are also developing Indonesia into a clinical research hub, creating an end-to-end ecosystem that supports everything from preclinical studies for new drug discovery to formulation research for improved therapies.

With long-term commitment, local empowerment, and global expertise, Daewoong continues to grow as Indonesia’s partner in innovation—driving meaningful impact for patients, communities, and the nation’s healthcare future.

Daewoong Indonesia

Org chart

Teams

Offices